Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance

PLoS Neglected Tropical Diseases

Volumn 6, Issue 7, 2012, Pages

  Symula, Rebecca E ^a,b   Beadell, Jon S ^a   Sistrom, Mark ^a   Agbebakun, Kehinde ^a   Balmer, Oliver ^c,d,e   Gibson, Wendy ^f   Aksoy, Serap ^a   Caccone, Adalgisa ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e RESEARCH INSTITUTE OF ORGANIC AGRICULTURE FIBL   (Switzerland)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN HAEMOGLOBIN RECEPTOR; LEUCINE; RECEPTOR; SERINE; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; HEMOGLOBIN HAPTOGLOBIN RECEPTOR; HEMOGLOBIN-HAPTOGLOBIN RECEPTOR; HIGH DENSITY LIPOPROTEIN; PROTOZOAL DNA; PROTOZOAL PROTEIN; TLF1 PROTEIN, HUMAN;

AFRICAN TRYPANOSOMIASIS; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; SEQUENCE ALIGNMENT; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA EVANSI; TRYPANOSOMA RHODESIENSE; AFRICA; CHEMISTRY; DNA SEQUENCE; GENETICS; IMMUNOLOGY; METABOLISM; MISSENSE MUTATION; MOLECULAR GENETICS; PATHOGENICITY; SERUM;

AFRICA; AMINO ACID SUBSTITUTION; DNA, PROTOZOAN; HUMANS; LIPOPROTEINS, HDL; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; SEQUENCE ANALYSIS, DNA; SERUM; TRYPANOSOMA BRUCEI GAMBIENSE;

EID: 84864601002     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001728     Document Type: Article

References (23)

1. Mehlitz D, Zillmann U, Scott CM, Godfrey DG, (1982) Epidemiological studies on the animal reservoir of Gambiense sleeping sickness. Part III. Characterization of Trypanozoon stocks by isoenzymes and sensitivity to human serum. Tropenmed Parasitol 33: 113-118.
2. Agbo EC, Majiwa PA, Claassen EJ, Roos MH, (2001) Measure of molecular diversity within the Trypanosoma brucei subspecies Trypanosoma brucei brucei and Trypanosoma brucei gambiense as revealed by genotypic characterization. Exp Parasitol 99: 123-131.
3. Gibson W, (2007) Resolution of the species problem in African trypanosomes. Int J Parasitol 37: 829-838.
4. Hajduk SL, Moore DR, Vasudevacharya J, Siqueira H, Torri AF, et al. (1989) Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. J Biol Chem 264: 5210-5217.
5. Pays E, Vanhollebeke B, (2009) Human innate immunity against African trypanosomes. Curr Opin Immunol 21: 493-498.
6. Vanhollebeke B, Pays E, (2010) The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill. Mol Microbiol 76: 806-814.
7. Wheeler RJ, (2010) The trypanolytic factor-mechanism, impacts and applications. Trends Parasitol 26: 457-464.
8. Xong HV, Vanhamme L, Chamekh M, Chimfwembe CE, Van Den Abbeele J, et al. (1998) A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95: 839-846.
9. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, et al. (2003) Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422: 83-87.
10. Capewell P, Veitch NJ, Turner CM, Raper J, Berriman M, et al. (2011) Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1. PLoS Negl Trop Dis 5: e1287.
11. Kieft R, Capewell P, Turner CM, Veitch NJ, MacLeod A, et al. (2010) Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proc Natl Acad Sci U S A 107: 16137-16141.
12. Koffi M, De Meeus T, Bucheton B, Solano P, Camara M, et al. (2009) Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa. Proc Natl Acad Sci U S A 106: 209-214.
13. Simo G, Njiokou F, Tume C, Lueong S, De Meeus T, et al. (2010) Population genetic structure of Central African Trypanosoma brucei gambiense isolates using microsatellite DNA markers. Infect Genet Evol 10: 68-76.
14. Gibson WC, de C. Marshall TF, Godfrey DG, (1980) Numerical analysis of enzyme polymorphism: a new approach to the epidemiology and taxonomy of trypanosomes of the subgenus Trypanozoon. Adv Parasitol 18: 175-246.
15. Tait A, Barry JD, Wink R, Sanderson A, Crowe JS, (1985) Enzyme variation in T. brucei ssp. II. Evidence for T. b. rhodesiense being a set of variants of T. b. brucei. Parasitology 90 (Pt 1): 89-100.
16. MacLeod A, Welburn S, Maudlin I, Turner CM, Tait A, (2001) Evidence for multiple origins of human infectivity in Trypanosoma brucei revealed by minisatellite variant repeat mapping. J Mol Evol 52: 290-301.
17. Balmer O, Beadell JS, Gibson W, Caccone A, (2011) Phylogeography and taxonomy of Trypanosoma brucei. PLoS Negl Trop Dis 5: e961.
18. Maddison DR, Maddison WP, (2006) MacClade4: Analysis of phylogeny and character evolution. 4.08 ed Sunderland, MA Sinauer Associates.
19. Flot JF, (2011) seqphase: a web tool for interconverting phase input/output files and fasta sequence alignments. Mol Ecol Resour 10: 162-166.
20. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
21. Clement M, Posada D, Crandall KA, (2000) TCS: a computer program to estimate gene genealogies. Mol Ecol 9: 1657-1659.
22. Vanhollebeke B, De Muylder G, Nielsen MJ, Pays A, Tebabi P, et al. (2008) A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 320: 677-681.
23. Higgins M, Tkachenko O, Brown S, Reed J, Carrington M, (In Review) Structure of the trypanosome haptoglobin haemoglobin receptor and its implications for receptor function and innate immunity. Nat Struct Mol Biol.